Literature DB >> 10417377

Deficient cellular immunity--finding and fixing the defects.

P D Greenberg1, S R Riddell.   

Abstract

The critical role of cellular immunity in resistance to infectious diseases is glaringly revealed by life-threatening infections if T cell function is disrupted by an inherited or acquired immunodeficiency. Although treatment has historically focused on infectious complications, understanding of the cellular and molecular basis of immunodeficiency and technologies useful for enhancing cellular immunity have both been rapidly evolving. A new era of molecular and cellular therapy is emerging as approaches to correct abnormal genes, the loss of T cell subpopulations, and aberrant T cell homeostasis make the transition from bench to bedside.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417377     DOI: 10.1126/science.285.5427.546

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease.

Authors:  R Salerno-Gonçalves; W Lu; J M Andrieu
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.

Authors:  S R Sarawar; B J Lee; S K Reiter; S P Schoenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies.

Authors:  Syam Tammana; Xin Huang; Marianna Wong; Michael C Milone; Linan Ma; Bruce L Levine; Carl H June; John E Wagner; Bruce R Blazar; Xianzheng Zhou
Journal:  Hum Gene Ther       Date:  2010-01       Impact factor: 5.695

4.  Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation.

Authors:  Naoki Kunii; Yangbing Zhao; Shuguang Jiang; Xiaojun Liu; John Scholler; Lakshmi Balagopalan; Lawrence E Samelson; Michael C Milone; Carl H June
Journal:  Hum Gene Ther       Date:  2012-11-06       Impact factor: 5.695

5.  Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Authors:  Xin Huang; Andrew C Wilber; Lei Bao; Dong Tuong; Jakub Tolar; Paul J Orchard; Bruce L Levine; Carl H June; R Scott McIvor; Bruce R Blazar; Xianzheng Zhou
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

6.  CD4(+) CD44(v.low) cells are unique peripheral precursors that are distinct from recent thymic emigrants and stem cell-like memory cells.

Authors:  Chunfang Zhao; Idania Marrero; Aditi Narsale; Rosita Moya; Joanna D Davies
Journal:  Cell Immunol       Date:  2015-04-17       Impact factor: 4.868

Review 7.  Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.

Authors:  Matjaz Jeras; Irena Bricl; Robert Zorec; Urban Svajger
Journal:  J Biomed Biotechnol       Date:  2010-03-10

8.  A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.

Authors:  Aparna Krishnan; Zhongde Wang; Tumul Srivastava; Ravindra Rawal; Pooja Manchanda; Don J Diamond; Corinna La Rosa
Journal:  Immunol Lett       Date:  2008-08-13       Impact factor: 3.685

Review 9.  Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus disease.

Authors:  Dean G Cruess; Steven D Douglas; John M Petitto; Jane Leserman; Thomas Ten Have; David Gettes; Benoit Dubé; Dwight L Evans
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

10.  An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse.

Authors:  Sylvia E Le Dévédec; Wies van Roosmalen; Naomi Maria; Max Grimbergen; Chantal Pont; Reshma Lalai; Bob van de Water
Journal:  Clin Exp Metastasis       Date:  2009-05-24       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.